Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Ganglioside GM
1
in acute ischemic stroke: The SASS trial
Neurology
College of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
62
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ganglioside GM
1
in acute ischemic stroke: The SASS trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Placebo
100%
Brain Ischemia
100%
Ganglioside GM1
100%
Barthel Index
100%
Death
50%
Blindness
50%
Depression
50%
Disease
50%
Neuroscience
Stroke
100%
Ganglioside GM1
100%
Brain Ischemia
100%
Placebo
66%
Depression
33%
Psychology
Group
100%
Clinical Trial
40%
Depression
20%